Work for Syndax Pharmaceuticals Inc?

Claim Your Profile

Syndax Pharmaceuticals Inc Logo Image

Syndax Pharmaceuticals Inc

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on

2016 Annual Report, Interactive Annual Report and Form 10K

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals Inc has reached its limit for free report views.

Syndax Pharmaceuticals Inc does not currently have any hardcopy reports on Click the button below to request a report when hardcopies become available.

About Syndax Pharmaceuticals Inc

51-200 Employees
Based in Waltham, Massachusetts

Syndax is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Company lead product candidate, entinostat, which was granted Breakthrough Therapy designation by the FDA following positive results from our Phase 2b clinical trial, ENCORE 301, is currently being evaluated in a Phase 3 clinical trial for advanced hormone receptor positive, human epidermal growth factor receptor 2 negative breast cancer.

NASDAQ (See More NASDAQ Companies)
--None-- (See More --None-- Companies)
--None-- (See More --None-- Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol